| Financial Year |
March 31 2023 |
| Monetary Funds |
3,347,803,034.96 |
| Held-for-trading Financial Assets |
300,000,000.00 |
| Notes Receivable |
2,361,496,761.27 |
| Accounts Receivable |
2,260,216,754.01 |
| Advances to Suppliers |
51,999,028.55 |
| Other Receivables |
4,516,997.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,395,296,391.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,531,216,999.25 |
| Total Current Assets |
11,252,545,966.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,472,807,928.86 |
| Under-construction Projects |
282,354,843.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
806,493,472.06 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,304,467.92 |
| Deferred Income Tax Assets |
72,545,435.68 |
| Other Non-Current Assets |
470,727,954.80 |
| Sub-Total of Non-Current Assets |
4,134,168,154.81 |
| Total Assets |
15,386,714,121.70 |
| Short-Term Loans |
6,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
752,413,721.09 |
| Accounts Payable |
932,692,006.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
273,582,397.41 |
| Taxes Payable |
49,722,977.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,957,647.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,995,330.35 |
| Other Current Liabilities |
42,620,203.69 |
| Sub-Total of Current Liabilities |
2,689,225,379.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
570,763,724.64 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,296,930.07 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
174,970,000.00 |
| Sub-Total of Non-Current Liabilities |
956,606,094.22 |
| Total Liabilities |
3,645,831,474.13 |
| Paid-In Capital(Or Share Stock) |
1,315,184,001.00 |
| Capital Surplus |
6,683,257,717.06 |
| Surplus Reserve |
139,038,844.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,251,718,052.13 |
| Minority Stockholder's Interest |
324,150,244.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,416,732,402.65 |
| Owner's Equity（Stockholder's Equity） |
11,740,882,647.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,386,714,121.70 |
